AL glycosylation,2 can make it bind more easily to
the outside of cells—think of this as making the protein stickier. This binding can play a role in many crucial processes, including cell prolifera- tion and migration.
Requiring repeatability “The life science community acknowledges that
biological variability is so great that we have to think of new ways to tackle the challenges,” says Mark Cafazzo, director of academic and omics business at SCIEX (Framingham, Mass.). “That typically requires a greater degree of repro- ducibility and larger study sets than what most proteomics labs are used to.” He adds, “Then you let the data speak for themselves.” And that means sizeable data sets. “The last few years, we have seen growing interest in looking at a large number of proteins in large sample sets to understand differences in populations,” Cafazzo says. “MS offers the ability to dig in and properly identify proteins, which we’ve done for years, and now we can do it with more comprehensive quantitation.”
SCIEX’s SWATH Acquisition software simultane- ously examines thousands of proteins. “If the sample is complex enough,” Cafazzo explains, “SWATH can quantify more than 5000 proteins over a dynamic range of 4.5 linear orders of response.” He adds, “That lets you dig deep into the proteome and see as much as possible, and do so reproducibly.”
In the past, MS identified proteins sequentially, basically one peptide at a time. Today, SWATH is fast enough to collect fragmentation data for all of the detectable ions in a sample in a data-independent approach. “It also does this on a time scale that is appropriate to the liquid-chromatography separation upstream,” Cafazzo explains. “You get a digital archive of all of the fragmentation data for all of the detect- able peptides in the sample.”
To generate data even faster, samples can be run at a higher flow rate—say, moving from nano- liters per minute to microliters per minute. To help life scientists manage the data, SCIEX part- ners with San Diego-based Illumina to provide customers with a data cloud where proteomic data can be combined with genomic data ac- quired from next-generation sequencing. This approach might go beyond proteomics. “Other
SCIEX’s SWATH Acquisition uses MS to simultaneously examine thousands of proteins. (Image courtesy of SCIEX.)
life science-oriented disciplines, like lipidomics and metabolomics, could also benefit from such techniques,” Cafazzo says, adding, “You capture more data in less time and throw more data at the problem—letting the statistics overcome the biological variability.”
Light speed At the 2015 annual meeting of the American
Society of Mass Spec-trometry, Bruker intro- duced the rapidfleX MALDI Tissuetyper. This matrix-assisted laser desorption ionization (MALDI) imaging platform relies on a high- repetition-rate laser, the smartbeam 3D, which can turn on and off as fast as 10,000 times a sec- ond. “With this device, you can actually image tissue samples and look for drug concentration [within] or disease states of tissues directly,” says Galvin. “This links biology with medicine.”
Getting so much from MS requires advances in hardware, such as a superfast laser, as well as improvements in software. Bruker’s flexImaging software runs the data acquisition and visualization. The platform uses SCiLS Lab software—developed by SCiLS GmbH (Bremen, Germany)—for statistical analysis that can mine data, even with advanced techniques like multivariate analysis.
Today’s MS, says Galvin, turns what once took two days to accomplish into a process that
AMERICAN LABORATORY 33 MAY 2016
takes just a few hours, and some platforms make that very easy. Bruker’s MALDI Biotyper, which identifies bacteria, “is becoming a black box where you put in a sample, press a button and the instrument does the analysis,” Galvin says. In brief, this platform looks for a unique molecular fingerprint—a collection of pro- teins—that identifies an organism.
As a result of improving ease of use, more life scientists use MS. According to Galvin, “A decade ago, these instruments were in core facilities, and now you are seeing them in labs where the biologists are doing the analysis directly.” That increases the depth at which life science can be explored, which expands our knowledge of processes behind diseases, evolution and much more.
References 1. Wan, C.; Borgeson, B. et al. Panorama of
ancient metazoan macromolecular com- plexes. Nature 2015, 525, 339–44.
2. Morelle, W. Michalski, J.-C. Analysis of pro- tein glycosylation by mass spectrometry. Nature Protocols 2007, 2, 1585–1602.
Mike May is a freelance writer and editor living in Ohio. He can be reached at mikemay1959@
gmail.com.
Page 1 |
Page 2 |
Page 3 |
Page 4 |
Page 5 |
Page 6 |
Page 7 |
Page 8 |
Page 9 |
Page 10 |
Page 11 |
Page 12 |
Page 13 |
Page 14 |
Page 15 |
Page 16 |
Page 17 |
Page 18 |
Page 19 |
Page 20 |
Page 21 |
Page 22 |
Page 23 |
Page 24 |
Page 25 |
Page 26 |
Page 27 |
Page 28 |
Page 29 |
Page 30 |
Page 31 |
Page 32 |
Page 33 |
Page 34 |
Page 35 |
Page 36 |
Page 37 |
Page 38 |
Page 39 |
Page 40 |
Page 41 |
Page 42 |
Page 43 |
Page 44 |
Page 45 |
Page 46 |
Page 47 |
Page 48 |
Page 49 |
Page 50 |
Page 51 |
Page 52 |
Page 53 |
Page 54 |
Page 55 |
Page 56 |
Page 57 |
Page 58 |
Page 59 |
Page 60